Cannara Biotech Inc., a prominent player in the cannabis industry, is headquartered in Canada and operates primarily in Quebec and Ontario. Founded in 2018, the company has quickly established itself as a leader in the cultivation and production of high-quality cannabis products. Cannara Biotech focuses on innovative solutions in the recreational and medicinal cannabis markets, offering a diverse range of products that include dried flower, pre-rolls, and oils. What sets Cannara apart is its commitment to sustainable practices and advanced cultivation techniques, ensuring premium quality while minimising environmental impact. With a strong market position and notable achievements, including rapid growth and strategic partnerships, Cannara Biotech Inc. continues to redefine the cannabis landscape, catering to a growing consumer base seeking reliable and effective cannabis solutions.
How does Cannara Biotech Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cannara Biotech Inc.'s score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cannara Biotech Inc., headquartered in Canada, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cannara Biotech may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate strategies and targets to align with best practices in environmental responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cannara Biotech Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
